<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Neutralizing antibodies directed against the envelope (E) protein have been identified as correlates of protection for vaccines Japanese encephalitis virus (JEV), yellow fever virus, and tickborne encephalitis viruses
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>
 </sup>. Other laboratories using different vaccine platforms (DNA, RNA, inactivated virus, protein subunit, adenovirus-vectored, VLP) have reported induction of ZIKV-specific neutralizing antibodies that conferred protection against live ZIKV challenge in animal models
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>–
  <xref ref-type="bibr" rid="CR8">8</xref>,
  <xref ref-type="bibr" rid="CR16">16</xref>–
  <xref ref-type="bibr" rid="CR22">22</xref>
 </sup>. These data support ZIKV E-specific neutralizing antibodies as a mechanism of protection against ZIKV infection.
</p>
